The Prognostic Significance of Tryptophanyl-tRNA Synthetase in Colorectal Cancer

被引:59
作者
Ghanipour, Arezo [1 ]
Jirstrom, Karin [4 ,5 ]
Ponten, Fredrik [2 ]
Glimelius, Bengt [3 ,6 ]
Pahlman, Lars [1 ]
Birgisson, Helgi [1 ]
机构
[1] Uppsala Univ, Dept Surg, Uppsala, Sweden
[2] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden
[3] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden
[4] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Ctr Mol Pathol, Malmo, Sweden
[5] Lund Univ, CREATE Hlth Ctr Translat Canc Res, Lund, Sweden
[6] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden
关键词
ENDOTHELIAL GROWTH-FACTOR; HUMAN PROTEIN ATLAS; TISSUE MICROARRAYS; FACTOR EXPRESSION; TUMOR-MARKERS; COLON-CANCER; VEGF-C; ANGIOGENESIS; FRAGMENT; THERAPY;
D O I
10.1158/1055-9965.EPI-09-0456
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Tryptophanyl-tRNA synthetase (TrpRS) is an aminoacyl-tRNA synthetase involved in protein synthesis and regulation of RNA transcription and translation and is an inhibitor of angiogenesis. TrpRS has been shown to be differentially expressed in colorectal cancer (CRC) and has thus been identified as a potential prognostic marker. The aim of this study was to analyze the correlation of TrpRS to the prognosis of patients diagnosed and treated for CRC within a defined population. Methods: With a polyclonal, monospecific IgG antibody, TrpRS expression was assessed by immunohistochemistry on tissue microarrays with tumors from a population-based CRC cohort (n = 320). Staining intensity and fraction of positive tumor cells were recorded. A Cox multivariate model including TrpRS expression, carcinoembryonic antigen, age, stage, tumor differentiation, and lymphatic and vascular vessel invasion was used to calculate the hazard ratio and 95% confidence interval (95% CI) for time to recurrence, disease-free survival, and overall survival. Results: Low expression of TrpRS correlated to increased risk for lymph node metastasis (P = 0.025) and a more advanced tumor stage (P = 0.001). Patients with tumors and increased levels of TrpRS expression had better survival than patients with low expression levels. Multivariate analyses revealed significantly better disease-free survival (relative risk, 0.59; 95% CI, 0.38-0.95) for patients with high expression than for patients with low expression of TrpRS. For colon cancer patients, a reduced risk for recurrence was seen in patients with increased TrpRS expression (relative risk, 0.23; 95% CI, 0.07-0.80). Conclusion: Low expression of TrpRS in tumor tissue correlates with increased risk for recurrence and worse survival in patients with CRC. This can be related to its antiangiogenic properties and could aid in the future selection of new drugs in the treatment of CRC. (Cancer Epidemiol Biomarkers Prev 2009;18(11):2949-56)
引用
收藏
页码:2949 / 2956
页数:8
相关论文
共 50 条
  • [41] Prognostic Significance of TRAIL Signaling Molecules in Stage II and III Colorectal Cancer
    McLornan, Donal P.
    Barrett, Helen L.
    Cummins, Robert
    McDermott, Ultan
    McDowell, Cliona
    Conlon, Susie J.
    Coyle, Victoria M.
    Van Schaeybroeck, Sandra
    Wilson, Richard
    Kay, Elaine W.
    Longley, Daniel B.
    Johnston, Patrick G.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (13) : 3442 - 3451
  • [42] Role of lymphatic vessel density in colorectal cancer : prognostic significance and clinicopathologic correlations
    Pappas, Apostolos
    Lagoudianakis, Emmanouil
    Seretis, Charalambos
    Koronakis, Nikolaos
    Keramidaris, Dimitrios
    Grapatsas, Konstantinos
    Filis, Konstantinos
    Manouras, Andreas
    Salemis, Nikolaos
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2015, 78 (02): : 223 - 227
  • [43] Clinical Significance of the Glasgow Prognostic Score for Survival after Colorectal Cancer Surgery
    Eren, Tunc
    Burcu, Busra
    Tombalak, Ercument
    Ozdemir, Tugrul
    Leblebici, Metin
    Ozemir, Ibrahim Ali
    Ziyade, Sedat
    Alimoglu, Orhan
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 20 (06) : 1231 - 1238
  • [44] Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer
    Zafirellis, Kyriakos
    Agrogiannis, George
    Zachaki, Aglaia
    Gravani, Katerina
    Karameris, Andreas
    Kombouras, Christos
    [J]. JOURNAL OF SURGICAL RESEARCH, 2008, 147 (01) : 99 - 107
  • [45] Prognostic significance of detection of microscopic peritoneal disease in colorectal cancer: A systematic review
    Mohan, Helen M.
    O'Connor, Donal B.
    O'Riordan, James M.
    Winter, Des C.
    [J]. SURGICAL ONCOLOGY-OXFORD, 2013, 22 (02): : E1 - E6
  • [46] Prognostic significance of lymphovascular or perineural invasion in patients with locally advanced colorectal cancer
    Huh, Jung Wook
    Lee, Jae Hyuk
    Kim, Hyeong Rok
    Kim, Young Jin
    [J]. AMERICAN JOURNAL OF SURGERY, 2013, 206 (05) : 758 - 763
  • [47] Expression and prognostic significance of GATA-binding protein 2 in colorectal cancer
    Chen, Lei
    Jiang, Beihai
    Wang, Zaozao
    Liu, Maoxing
    Ma, Yiyuan
    Yang, Hong
    Xing, Jiadi
    Zhang, Chenghai
    Yao, Zhendan
    Zhang, Nan
    Cui, Ming
    Su, Xiangqian
    [J]. MEDICAL ONCOLOGY, 2013, 30 (02)
  • [48] Prognostic significance of vascular endothelial growth factor polymorphisms in colorectal cancer patients
    do Espirito Santo, Gilmar Ferreira
    Galera, Bianca Borsatto
    Duarte, Elisabeth Carmen
    Chen, Elisabeth Suchi
    Azis, Lenuce
    Damazo, Amilcar Sabino
    Saba, Gabriela Tognini
    Gehrke, Flavia de Sousa
    Cotrim Guerreiro da Silva, Ismael Dale
    Waisberg, Jaques
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 9 (02) : 78 - 86
  • [49] Inducible nitric oxide synthase expression and its prognostic significance in colorectal cancer
    Zafirellis, Kyriakos
    Zachaki, Aglaia
    Agrogiannis, George
    Gravani, Katerina
    [J]. APMIS, 2010, 118 (02) : 115 - 124
  • [50] Prognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer
    Shibutani, Masatsune
    Maeda, Kiyoshi
    Nagahara, Hisashi
    Iseki, Yasuhito
    Ikeya, Tetsuro
    Hirakawa, Kosei
    [J]. ONCOLOGY LETTERS, 2017, 13 (02) : 1000 - 1006